Overview

Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
Phase:
Phase 3
Details
Lead Sponsor:
Fudan University
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel